Nick Basile
Ascalon Capital Managers has joined with Brett McElwee, Max Cappetta and Anthony Corr to establish a new boutique, Continuum Capital Management.
The new manager style is described as “a quantitative investment boutique”.
Continuum Capital Management will initially focus on the domestic equities market, targeting core, high alpha and long short products.
According to the company, its investment process will be “pure quant from end-to-end, from data capture and quality assurance, through to research, portfolio construction, trade creation and ultimately implementation”.
Continuum will benchmark its portfolios to an after-tax benchmark, and see this as the future of the funds management industry.
The three principals have over 30 years experience in the quantitative investment space.
Corr and Cappetta both left GMO Australia in September after 10 years with the company.
Corr was head of equities research, while Cappetta was executive director and head of Australian equities.
McElwee was a founding partner and director of quant at MIR Investment Management before departing in February 2007. Prior to this he worked with Corr and Cappetta at GMO from 1998 to 2002.
Chief executive officer Ascalon Nick Basile and senior manager of investments Nelson Lam will be joining the three principals as Continuum board members. Ascalon specialises in developing and investing in boutique fund managers.
“Continuum reunites three of Australia’s better respected and experienced ‘investment quants’ who have the vision and capability to deliver enhanced and distinctive quantitative offering to meet the ever evolving and complex needs of the professional market and is Ascalon’s latest investment in its stable of eight boutique investment businesses,” Basile said.
